Experience
Selected Clients, 2005-2016 Prism Pharma Co., Ltd., Yokohama, Kanagawa, Japan 2013 - Present Quality, CMC, Bioanalytical and Project Manager Consultant - Lead, manage and/or facilitate high-level Clinical Services and CMC teams - Coordinate Clinical Development, CQA, PK, CMC, QA and Bioanalytical Chemistry in support of oncology programs Ceptaris/Yaupon Therapeutics/Actelion Pharmaceuticals, Inc., Malvern, PA 2011- 2014 Senior CMC/Quality Consultant - Managed most analytical R & D and QC activities with numerous vendors to support VALCHLOR API and drug product development - Coordinated all Frontage laboratory LC/MS drug product analytical method activities - Provided Quality Assurance support for audits, batch record review and related compliance activities Auxilium Pharmaceuticals, Inc. Malvern/Chesterbrook, PA 2006 – 2014 Senior Director/Senior Bioanalytical and Quality Consultant - Coordinated and developed ligand binding antigen/antibody and enzyme activity neutralizing antibody assays with CROs for XIAFLEX® and LC/MS/MS assays for transmucosal film (TMF) small molecule programs - Wrote and coordinated many analytical/nonclinical and clinical sections for XIAFLEX® BLA - Provided expert analytical advice to Horsham XiaFlex® manufacturing facility and coordinate related issues with CROs and partners - As Acting QC Director streamlined DI/CAPA/CC process for 34-person analytical and microbiology group; directed key scientific initiatives - Conducted CMC, bioanalytical and toxicology portions of TMF program - Mid-size Pharma Co. – Acted as Principal Investigator, Subject Matter Expert (SME) for remediation and verification of bioanalytical studies -Actelion Pharmaceuticals – Managed contract labs; drafted and finalized CMC regulatory responses for EMA submission - University of Maryland School of Pharmacy – Lectured and organized program in Bioanalytical Chemistry and Good Laboratory Practices (GLP) for on-line MS program in Regulatory Sciences -Asahi Kasei Pharma - Coordinated bioanalytical activities for submission of XIAFLEX® in Asian markets - Digestive Care, Inc. - Coordinated post-submission analytical/bioanalytical validation activities for PERTZYE™ (pancrelipase); NDA approval May 2012 - Johnson & Johnson - Project manager for worldwide dermatological R&D team and coordinated nasal spray testing program - Pfizer/Vicuron Pharmaceuticals, Inc., King of Prussia, PA 2005 - 2006 - Analytical - Directed post-NDA processes for dalbavancin, anidulafungin and a POP study; coordinated international analytical issues between Aventis, multiple CROs and Pfizer - Formulation, Chemistry- Coordinated with CROs on chemistry and formulation POP issues - RA- Addressed and wrote CMC responses for dalbavancin and IND filing for a POP compound